APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiviral Polymers for Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antiviral Polymers for Packaging Market Outlook and Growth Opportunities 2026

30 December 2025195 pages

Choose your research edition.

Industry ResearchAntiviral Polymers for Packaging Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiviral Polymers for Packaging Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Antiviral Polymers for Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiviral Polymers for Packaging Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiviral Polymers for Packaging Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Antiviral Polymers for Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antiviral Polymers for Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiviral Polymers for Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiviral Polymers for Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antiviral Polymers for Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antiviral Polymers for Packaging market include Dow Chemical, BASF SE, Mondi Plc, Amcor plc, Gerresheimer, AptarGroup Inc., BD and Schott AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antiviral Polymers for Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiviral Polymers for Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiviral Polymers for Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antiviral Polymers for Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiviral Polymers for Packaging Segment by Company

Dow Chemical

BASF SE

Mondi Plc

Amcor plc

Gerresheimer

AptarGroup Inc.

BD

Schott AG

Antiviral Polymers for Packaging Segment by Type

Bags and Pouches

Wrapping Films

Others

Antiviral Polymers for Packaging Segment by Application

Food and Beverages

Food Service

Healthcare

Personal Care

Others

Antiviral Polymers for Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antiviral Polymers for Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antiviral Polymers for Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antiviral Polymers for Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Antiviral Polymers for Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiviral Polymers for Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiviral Polymers for Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiviral Polymers for Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antiviral Polymers for Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antiviral Polymers for Packaging industry.

Chapter 3: Detailed analysis of Antiviral Polymers for Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antiviral Polymers for Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antiviral Polymers for Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antiviral Polymers for Packaging Industry Trends Table 2. Antiviral Polymers for Packaging Industry Drivers Table 3. Antiviral Polymers for Packaging Industry Opportunities and Challenges Table 4. Antiviral Polymers for Packaging Industry Restraints Table 5. Global Antiviral Polymers for Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antiviral Polymers for Packaging Revenue Share by Company (2021-2026) Table 7. Global Antiviral Polymers for Packaging Sales Volume by Company (k units) & (2021-2026) Table 8. Global Antiviral Polymers for Packaging Sales Volume Share by Company (2021-2026) Table 9. Global Antiviral Polymers for Packaging Average Price (USD/unit) of Company (2021-2026) Table 10. Global Antiviral Polymers for Packaging Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antiviral Polymers for Packaging Key Company Manufacturing Base & Headquarters Table 12. Global Antiviral Polymers for Packaging Company, Product Type & Application Table 13. Global Antiviral Polymers for Packaging Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antiviral Polymers for Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bags and Pouches Table 18. Significant Companies of Wrapping Films Table 19. Significant Companies of Others Table 20. Global Antiviral Polymers for Packaging Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Antiviral Polymers for Packaging Sales Volume by Type (2021-2026) & (k units) Table 22. Global Antiviral Polymers for Packaging Sales Volume by Type (2027-2032) & (k units) Table 23. Global Antiviral Polymers for Packaging Sales Volume Share by Type (2021-2026) Table 24. Global Antiviral Polymers for Packaging Sales Volume Share by Type (2027-2032) Table 25. Global Antiviral Polymers for Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antiviral Polymers for Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Antiviral Polymers for Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Antiviral Polymers for Packaging Sales Value Share by Type (2021-2026) Table 29. Global Antiviral Polymers for Packaging Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Food and Beverages Table 31. Significant Companies of Food Service Table 32. Significant Companies of Healthcare Table 33. Significant Companies of Personal Care Table 34. Significant Companies of Others Table 35. Global Antiviral Polymers for Packaging Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Antiviral Polymers for Packaging Sales Volume by Application (2021-2026) & (k units) Table 37. Global Antiviral Polymers for Packaging Sales Volume by Application (2027-2032) & (k units) Table 38. Global Antiviral Polymers for Packaging Sales Volume Share by Application (2021-2026) Table 39. Global Antiviral Polymers for Packaging Sales Volume Share by Application (2027-2032) Table 40. Global Antiviral Polymers for Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Antiviral Polymers for Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Antiviral Polymers for Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Antiviral Polymers for Packaging Sales Value Share by Application (2021-2026) Table 44. Global Antiviral Polymers for Packaging Sales Value Share by Application (2027-2032) Table 45. Global Antiviral Polymers for Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Antiviral Polymers for Packaging Sales by Region (2021-2026) & (k units) Table 47. Global Antiviral Polymers for Packaging Sales Market Share by Region (2021-2026) Table 48. Global Antiviral Polymers for Packaging Sales by Region (2027-2032) & (k units) Table 49. Global Antiviral Polymers for Packaging Sales Market Share by Region (2027-2032) Table 50. Global Antiviral Polymers for Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Antiviral Polymers for Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Antiviral Polymers for Packaging Sales Value Share by Region (2021-2026) Table 53. Global Antiviral Polymers for Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Antiviral Polymers for Packaging Sales Value Share by Region (2027-2032) Table 55. Global Antiviral Polymers for Packaging Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Antiviral Polymers for Packaging Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Antiviral Polymers for Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Antiviral Polymers for Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antiviral Polymers for Packaging Sales by Country (2021-2026) & (k units) Table 60. Global Antiviral Polymers for Packaging Sales Market Share by Country (2021-2026) Table 61. Global Antiviral Polymers for Packaging Sales by Country (2027-2032) & (k units) Table 62. Global Antiviral Polymers for Packaging Sales Market Share by Country (2027-2032) Table 63. Global Antiviral Polymers for Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Antiviral Polymers for Packaging Sales Value Market Share by Country (2021-2026) Table 65. Global Antiviral Polymers for Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Antiviral Polymers for Packaging Sales Value Market Share by Country (2027-2032) Table 67. Dow Chemical Company Information Table 68. Dow Chemical Business Overview Table 69. Dow Chemical Antiviral Polymers for Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Dow Chemical Antiviral Polymers for Packaging Product Portfolio Table 71. Dow Chemical Recent Development Table 72. BASF SE Company Information Table 73. BASF SE Business Overview Table 74. BASF SE Antiviral Polymers for Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. BASF SE Antiviral Polymers for Packaging Product Portfolio Table 76. BASF SE Recent Development Table 77. Mondi Plc Company Information Table 78. Mondi Plc Business Overview Table 79. Mondi Plc Antiviral Polymers for Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Mondi Plc Antiviral Polymers for Packaging Product Portfolio Table 81. Mondi Plc Recent Development Table 82. Amcor plc Company Information Table 83. Amcor plc Business Overview Table 84. Amcor plc Antiviral Polymers for Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Amcor plc Antiviral Polymers for Packaging Product Portfolio Table 86. Amcor plc Recent Development Table 87. Gerresheimer Company Information Table 88. Gerresheimer Business Overview Table 89. Gerresheimer Antiviral Polymers for Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Gerresheimer Antiviral Polymers for Packaging Product Portfolio Table 91. Gerresheimer Recent Development Table 92. AptarGroup Inc. Company Information Table 93. AptarGroup Inc. Business Overview Table 94. AptarGroup Inc. Antiviral Polymers for Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. AptarGroup Inc. Antiviral Polymers for Packaging Product Portfolio Table 96. AptarGroup Inc. Recent Development Table 97. BD Company Information Table 98. BD Business Overview Table 99. BD Antiviral Polymers for Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. BD Antiviral Polymers for Packaging Product Portfolio Table 101. BD Recent Development Table 102. Schott AG Company Information Table 103. Schott AG Business Overview Table 104. Schott AG Antiviral Polymers for Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Schott AG Antiviral Polymers for Packaging Product Portfolio Table 106. Schott AG Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Antiviral Polymers for Packaging Distributors List Table 110. Antiviral Polymers for Packaging Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Antiviral Polymers for Packaging Product Image Figure 2. Global Antiviral Polymers for Packaging Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiviral Polymers for Packaging Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antiviral Polymers for Packaging Sales (2021-2032) & (k units) Figure 5. Global Antiviral Polymers for Packaging Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Antiviral Polymers for Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bags and Pouches Image Figure 10. Wrapping Films Image Figure 11. Others Image Figure 12. Global Antiviral Polymers for Packaging Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Antiviral Polymers for Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Antiviral Polymers for Packaging Sales Volume Share by Type (2021-2032) Figure 15. Global Antiviral Polymers for Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Antiviral Polymers for Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Antiviral Polymers for Packaging Sales Value Share by Type (2021-2032) Figure 18. Food and Beverages Image Figure 19. Food Service Image Figure 20. Healthcare Image Figure 21. Personal Care Image Figure 22. Others Image Figure 23. Global Antiviral Polymers for Packaging Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Antiviral Polymers for Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Antiviral Polymers for Packaging Sales Volume Share by Application (2021-2032) Figure 26. Global Antiviral Polymers for Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antiviral Polymers for Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Antiviral Polymers for Packaging Sales Value Share by Application (2021-2032) Figure 29. Global Antiviral Polymers for Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Antiviral Polymers for Packaging Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Antiviral Polymers for Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Antiviral Polymers for Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Antiviral Polymers for Packaging Sales Value (2021-2032) & (US$ Million) Figure 34. North America Antiviral Polymers for Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Antiviral Polymers for Packaging Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Antiviral Polymers for Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Antiviral Polymers for Packaging Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Antiviral Polymers for Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Antiviral Polymers for Packaging Sales Value (2021-2032) & (US$ Million) Figure 40. South America Antiviral Polymers for Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Antiviral Polymers for Packaging Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Antiviral Polymers for Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Antiviral Polymers for Packaging Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Antiviral Polymers for Packaging Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Bags and Pouches
  • Wrapping Films
  • Others
Applications
  • Food and Beverages
  • Food Service
  • Healthcare
  • Personal Care
  • Others
Companies covered
  • Dow Chemical
  • BASF SE
  • Mondi Plc
  • Amcor plc
  • Gerresheimer
  • AptarGroup Inc.
  • BD
  • Schott AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiviral Polymers for Packaging Sales Value (2021-2032)
  4. 1.2.2 Global Antiviral Polymers for Packaging Sales Volume (2021-2032)
  5. 1.2.3 Global Antiviral Polymers for Packaging Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antiviral Polymers for Packaging Market Dynamics
  1. 2.1 Antiviral Polymers for Packaging Industry Trends
  2. 2.2 Antiviral Polymers for Packaging Industry Drivers
  3. 2.3 Antiviral Polymers for Packaging Industry Opportunities and Challenges
  4. 2.4 Antiviral Polymers for Packaging Industry Restraints
3 Antiviral Polymers for Packaging Market by Company
  1. 3.1 Global Antiviral Polymers for Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Antiviral Polymers for Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Antiviral Polymers for Packaging Sales Volume by Company (2021-2026)
  4. 3.4 Global Antiviral Polymers for Packaging Average Price by Company (2021-2026)
  5. 3.5 Global Antiviral Polymers for Packaging Company Ranking (2024-2026)
  6. 3.6 Global Antiviral Polymers for Packaging Company Manufacturing Base and Headquarters
  7. 3.7 Global Antiviral Polymers for Packaging Company Product Type and Application
  8. 3.8 Global Antiviral Polymers for Packaging Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antiviral Polymers for Packaging Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antiviral Polymers for Packaging Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antiviral Polymers for Packaging Market by Type
  1. 4.1 Antiviral Polymers for Packaging Type Introduction
  2. 4.1.1 Bags and Pouches
  3. 4.1.2 Wrapping Films
  4. 4.1.3 Others
  5. 4.2 Global Antiviral Polymers for Packaging Sales Volume by Type
  6. 4.2.1 Global Antiviral Polymers for Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antiviral Polymers for Packaging Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Antiviral Polymers for Packaging Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Antiviral Polymers for Packaging Sales Value by Type
  10. 4.3.1 Global Antiviral Polymers for Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antiviral Polymers for Packaging Sales Value by Type (2021-2032)
  12. 4.3.3 Global Antiviral Polymers for Packaging Sales Value Share by Type (2021-2032)
5 Antiviral Polymers for Packaging Market by Application
  1. 5.1 Antiviral Polymers for Packaging Application Introduction
  2. 5.1.1 Food and Beverages
  3. 5.1.2 Food Service
  4. 5.1.3 Healthcare
  5. 5.1.4 Personal Care
  6. 5.1.5 Others
  7. 5.2 Global Antiviral Polymers for Packaging Sales Volume by Application
  8. 5.2.1 Global Antiviral Polymers for Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Antiviral Polymers for Packaging Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Antiviral Polymers for Packaging Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Antiviral Polymers for Packaging Sales Value by Application
  12. 5.3.1 Global Antiviral Polymers for Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Antiviral Polymers for Packaging Sales Value by Application (2021-2032)
  14. 5.3.3 Global Antiviral Polymers for Packaging Sales Value Share by Application (2021-2032)
6 Antiviral Polymers for Packaging Regional Sales and Value Analysis
  1. 6.1 Global Antiviral Polymers for Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antiviral Polymers for Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Antiviral Polymers for Packaging Sales by Region: 2021-2026
  4. 6.2.2 Global Antiviral Polymers for Packaging Sales by Region (2027-2032)
  5. 6.3 Global Antiviral Polymers for Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antiviral Polymers for Packaging Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antiviral Polymers for Packaging Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antiviral Polymers for Packaging Sales Value by Region (2027-2032)
  9. 6.5 Global Antiviral Polymers for Packaging Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antiviral Polymers for Packaging Sales Value (2021-2032)
  12. 6.6.2 North America Antiviral Polymers for Packaging Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antiviral Polymers for Packaging Sales Value (2021-2032)
  15. 6.7.2 Europe Antiviral Polymers for Packaging Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antiviral Polymers for Packaging Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antiviral Polymers for Packaging Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antiviral Polymers for Packaging Sales Value (2021-2032)
  21. 6.9.2 South America Antiviral Polymers for Packaging Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antiviral Polymers for Packaging Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antiviral Polymers for Packaging Sales Value Share by Country, 2025 VS 2032
7 Antiviral Polymers for Packaging Country-level Sales and Value Analysis
  1. 7.1 Global Antiviral Polymers for Packaging Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antiviral Polymers for Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antiviral Polymers for Packaging Sales by Country (2021-2032)
  4. 7.3.1 Global Antiviral Polymers for Packaging Sales by Country (2021-2026)
  5. 7.3.2 Global Antiviral Polymers for Packaging Sales by Country (2027-2032)
  6. 7.4 Global Antiviral Polymers for Packaging Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antiviral Polymers for Packaging Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antiviral Polymers for Packaging Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antiviral Polymers for Packaging Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antiviral Polymers for Packaging Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antiviral Polymers for Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Dow Chemical
  2. 8.1.1 Dow Chemical Company Information
  3. 8.1.2 Dow Chemical Business Overview
  4. 8.1.3 Dow Chemical Antiviral Polymers for Packaging Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Dow Chemical Antiviral Polymers for Packaging Product Portfolio
  6. 8.1.5 Dow Chemical Recent Developments
  7. 8.2 BASF SE
  8. 8.2.1 BASF SE Company Information
  9. 8.2.2 BASF SE Business Overview
  10. 8.2.3 BASF SE Antiviral Polymers for Packaging Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BASF SE Antiviral Polymers for Packaging Product Portfolio
  12. 8.2.5 BASF SE Recent Developments
  13. 8.3 Mondi Plc
  14. 8.3.1 Mondi Plc Company Information
  15. 8.3.2 Mondi Plc Business Overview
  16. 8.3.3 Mondi Plc Antiviral Polymers for Packaging Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mondi Plc Antiviral Polymers for Packaging Product Portfolio
  18. 8.3.5 Mondi Plc Recent Developments
  19. 8.4 Amcor plc
  20. 8.4.1 Amcor plc Company Information
  21. 8.4.2 Amcor plc Business Overview
  22. 8.4.3 Amcor plc Antiviral Polymers for Packaging Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Amcor plc Antiviral Polymers for Packaging Product Portfolio
  24. 8.4.5 Amcor plc Recent Developments
  25. 8.5 Gerresheimer
  26. 8.5.1 Gerresheimer Company Information
  27. 8.5.2 Gerresheimer Business Overview
  28. 8.5.3 Gerresheimer Antiviral Polymers for Packaging Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Gerresheimer Antiviral Polymers for Packaging Product Portfolio
  30. 8.5.5 Gerresheimer Recent Developments
  31. 8.6 AptarGroup Inc.
  32. 8.6.1 AptarGroup Inc. Company Information
  33. 8.6.2 AptarGroup Inc. Business Overview
  34. 8.6.3 AptarGroup Inc. Antiviral Polymers for Packaging Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AptarGroup Inc. Antiviral Polymers for Packaging Product Portfolio
  36. 8.6.5 AptarGroup Inc. Recent Developments
  37. 8.7 BD
  38. 8.7.1 BD Company Information
  39. 8.7.2 BD Business Overview
  40. 8.7.3 BD Antiviral Polymers for Packaging Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BD Antiviral Polymers for Packaging Product Portfolio
  42. 8.7.5 BD Recent Developments
  43. 8.8 Schott AG
  44. 8.8.1 Schott AG Company Information
  45. 8.8.2 Schott AG Business Overview
  46. 8.8.3 Schott AG Antiviral Polymers for Packaging Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Schott AG Antiviral Polymers for Packaging Product Portfolio
  48. 8.8.5 Schott AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antiviral Polymers for Packaging Value Chain Analysis
  2. 9.1.1 Antiviral Polymers for Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antiviral Polymers for Packaging Sales Mode & Process
  6. 9.2 Antiviral Polymers for Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antiviral Polymers for Packaging Distributors
  9. 9.2.3 Antiviral Polymers for Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst